Author

G. Stein

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Scientific Communication & Education· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:database / resource· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

A. D. Borowsky· 1 shared A. Glencer· 1 shared A. Officer· 1 shared B. W. Day· 1 shared B. Wainwright· 1 shared C. Lim· 1 shared C. Offenhauser· 1 shared C. Yau· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. D. Borowsky

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Tumor microenvironmental determinants of high-risk DCIS progression

A. Glencer, K. Ramalingam, N. Schindler, H. Mori, P. Ghule, K. C. Lee, D. Nachmanson, A. Officer, O. Harismendy, J. L. Stein, G. Stein, D. Weaver, C. Yau, G. L. Hirst, M. J. Campbell, , A. D. Borowsky

This study identifies immune microenvironment features and myoepithelial continuity as key determinants of progression in high-risk DCIS.

bioRxiv · Dec 1, 2023 · PreprintCancer Biology

Targeting OLIG2 increases therapeutic responses in SHH medulloblastoma mouse models and patient-derived medulloblastoma organoids

Y. Li, T. Dismuke, C. Lim, Z. C. Bruce, C. Offenhauser, U. Baumgartner, M. Maybury, R. C. J. DSouza, T. Hassall, B. Wainwright, G. Stein, M. Piper, T. G. Johns, M. Sokolsky-Papkov, T. R. Gershon, B. W. Day

This study shows that targeting OLIG2 with CT-179 reduces recurrence in SHH medulloblastoma models and improves survival when combined with radiotherapy.

bioRxiv · Feb 14, 2022 · PreprintCancer Biology

The DocMaps Framework for representing assertions on research products in an extensible, machine-readable, and discoverable format

G. S. McDowell, J. K. Polka, T. Ross-Hellauer, G. Stein

The paper proposes a framework for representing machine-readable, extensible, and discoverable assertions about research products and editorial processes.

bioRxiv · Jul 13, 2021 · PreprintScientific Communication & Education